LGL Partners LLC Cuts Stake in Sabra Healthcare REIT, Inc. $SBRA

LGL Partners LLC lessened its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 79.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,145 shares of the real estate investment trust’s stock after selling 40,000 shares during the period. LGL Partners LLC’s holdings in Sabra Healthcare REIT were worth $198,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. PNC Financial Services Group Inc. raised its stake in shares of Sabra Healthcare REIT by 2.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock valued at $451,000 after acquiring an additional 528 shares in the last quarter. Larson Financial Group LLC grew its stake in Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares in the last quarter. Inspire Investing LLC grew its stake in Sabra Healthcare REIT by 2.3% during the 4th quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock worth $469,000 after purchasing an additional 565 shares in the last quarter. Nissay Asset Management Corp Japan grew its position in shares of Sabra Healthcare REIT by 1.5% during the second quarter. Nissay Asset Management Corp Japan now owns 38,957 shares of the real estate investment trust’s stock worth $760,000 after buying an additional 585 shares in the last quarter. Finally, Natixis Advisors LLC lifted its stake in Sabra Healthcare REIT by 2.2% in the third quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock worth $516,000 after acquiring an additional 598 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 1.1%

NASDAQ:SBRA opened at $20.39 on Tuesday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $22.77. The stock has a market capitalization of $5.21 billion, a price-to-earnings ratio of 78.43, a PEG ratio of 1.57 and a beta of 0.64. The stock has a fifty day moving average price of $20.47 and a two-hundred day moving average price of $20.17.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The company had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business’s revenue for the quarter was up 24.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.38 EPS. As a group, sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were given a $0.30 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 461.54%.

Analyst Ratings Changes

SBRA has been the topic of several recent analyst reports. Truist Financial increased their target price on Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Mizuho set a $21.00 price objective on shares of Sabra Healthcare REIT in a report on Monday. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Robert W. Baird boosted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Monday. Finally, Cantor Fitzgerald upped their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $22.17.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.